Listen to summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 15.
https://www.oncotarget.com/archive/v12/i15/
Cover Paper - “Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells”
https://doi.org/10.18632/oncotarget.28020
Research Paper - “RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans” https://doi.org/10.18632/oncotarget.28024
Research Paper - “Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis”
https://doi.org/10.18632/oncotarget.28011
Research Paper - “The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma” https://doi.org/10.18632/oncotarget.28025
Research Paper - “Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers” https://doi.org/10.18632/oncotarget.28022
Research Paper - “JunD accentuates arecoline-induced disruption of tight junctions and promotes epithelial-to-mesenchymal transition by association with NEAT1 lncRNA” https://doi.org/10.18632/oncotarget.28026
Research Paper - “Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase” https://doi.org/10.18632/oncotarget.28021
Editorial - “Multidisciplinary clinics in prostate cancer” https://doi.org/10.18632/oncotarget.27984 (PDF Download)
Research Perspective - “Developing next generation immunomodulatory drugs and their combinations in multiple myeloma”
https://doi.org/10.18632/oncotarget.27973
Keywords - chromosome instability, prostate cancer, sulforaphane, exosomes, head and neck cancer, miRNA, arecoline, biliary tract cancer, multiple myeloma, cancer, science, research, oncology
About Oncotarget
Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/oncotargetyoutube
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget
Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957
